End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,830 KRW | -1.26% | -0.47% | -18.34% |
2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
2023 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
Sales 2024 * | 635B 461M | Sales 2025 * | 680B 494M | Capitalization | 414B 301M |
---|---|---|---|---|---|
Net income 2024 * | 31B 22.51M | Net income 2025 * | 44B 31.94M | EV / Sales 2024 * | 0.65 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.61 x |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
9.29
x | Employees | 1,166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.42% |
1 day | -1.26% | ||
1 week | -0.47% | ||
Current month | -5.84% | ||
1 month | -12.09% | ||
3 months | -6.08% | ||
6 months | -6.79% | ||
Current year | -18.34% |
Managers | Title | Age | Since |
---|---|---|---|
Woong-Sub Yoon
CEO | Chief Executive Officer | 56 | 16-08-02 |
Gyu-Seong Kang
DFI | Director of Finance/CFO | 58 | - |
Jin-Shik Seo
COO | Chief Operating Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Woong-Sub Yoon
CEO | Chief Executive Officer | 56 | 16-08-02 |
Chang-Rok Seo
BRD | Director/Board Member | 62 | - |
Gyu-Seong Kang
DFI | Director of Finance/CFO | 58 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | -0.72% | - | |
0.00% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 14,830 | -1.26% | 59,181 |
24-04-19 | 15,020 | +1.42% | 129,708 |
24-04-18 | 14,810 | +2.85% | 54,076 |
24-04-17 | 14,400 | -0.76% | 48,218 |
24-04-16 | 14,510 | -2.62% | 96,544 |
End-of-day quote Korea S.E., April 21, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.34% | 300M | |
+25.46% | 659B | |
+25.38% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.13% | 215B | |
+2.93% | 210B | |
-7.65% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- A249420 Stock